Evidence map›Paper›PMID 33859241›Full record

ArticleScientific reports2021

Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease.

Daisy E Gates, Molly Staley, Luc Tardy, Mathieu Giraudeau, Geoffrey E Hill, Kevin J McGraw, Camille Bonneaud

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in microbiology · 2026
    Article
  4. Article
  5. Article
  6. Transboundary and emerging diseases · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Daisy E GatesCentre for Ecology and Conservation, University of Exeter, Penryn, Cornwall, TR10 9FE, UK.
Molly StaleyDepartment Biological Science, Auburn University, Auburn, Alabama, 36849-5414, USA.
Luc TardyCentre for Ecology and Conservation, University of Exeter, Penryn, Cornwall, TR10 9FE, UK.
Mathieu GiraudeauCentre for Ecology and Conservation, University of Exeter, Penryn, Cornwall, TR10 9FE, UK.
Geoffrey E HillDepartment Biological Science, Auburn University, Auburn, Alabama, 36849-5414, USA.
Kevin J McGrawSchool of Life Sciences, Arizona State University, Tempe, AZ, 85287-4501, USA.
Camille BonneaudCentre for Ecology and Conservation, University of Exeter, Penryn, Cornwall, TR10 9FE, UK. c.bonneaud@exeter.ac.uk.
University of Exeter · GBAuburn University · USArizona State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantifying variation in the ability to fight infection among free-living hosts is challenging and often constrained to one or a few measures of immune activity. While such measures are typically taken to reflect host resistance, they can also be shaped by pathogen effects, for example, if more virulent strains trigger more robust immune responses. Here, we test the extent to which pathogen-specific antibody levels, a commonly used measure of immunocompetence, reflect variation in host resistance versus pathogen virulence, and whether these antibodies effectively clear infection. House finches (Haemorhous mexicanus) from resistant and susceptible populations were inoculated with > 50 isolates of their novel Mycoplasma gallisepticum pathogen collected over a 20-year period during which virulence increased. Serum antibody levels were higher in finches from resistant populations and increased with year of pathogen sampling. Higher antibody levels, however, did not subsequently give rise to greater reductions in pathogen load. Our results show that antibody responses can be shaped by levels of host resistance and pathogen virulence, and do not necessarily signal immune clearance ability. While the generality of this novel finding remains unclear, particularly outside of mycoplasmas, it cautions against using antibody levels as implicit proxies for immunocompetence and/or host resistance.

Indexed as

FinchesAnimalsAntibody FormationBacterial InfectionsBehavior, AnimalBird DiseasesDisease ProgressionDisease ResistanceFemaleHost-Pathogen InteractionsMaleMycoplasma gallisepticumMycoplasma InfectionsVirulence

Identifiers

PMID33859241
PMCPMC8050079
OpenAlexW3156287187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.